Compare Mitra Angkasa Sejahtera Tbk. (BAUT) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitra Angkasa Sejahtera Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Mitra Angkasa Sejahtera Tbk. trades at Rp35 (market cap 168.01B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 29.7K 24h volume). The key difference: Mitra Angkasa Sejahtera Tbk. and Brigit Biofarmaka Teknologi Tbk. are close in size by market cap. Which is the better fit depends on your goals.
| BAUT | OBAT | |
|---|---|---|
Market Cap | 168.01B | 164.65B |
Indicative Equilibrium Price | 35 | 238 |
Indicative Equilibrium Volume | 521 | 100 |
Volume | — | 29.7K |
Lot | — | 297 |
Turnover | — | 7.18M |
Average Price | — | 241.73 |
Value | — | 7.18M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mitra Angkasa Sejahtera Tbk.
PT Mitra Angkasa Sejahtera Tbk (“the Company”) is established based on Deed of Establishment No. 63 dated November 19, 2012 made by Doktorandus Wijanto Suwongso, S.H., Notary in Jakarta. The Company started its commercial operations in 2016.
Read more on BAUT →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
